- RecruitingPHASE2
A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis
This study looks at a new medicine called Elritercept for myelofibrosis, a bone marrow condition. Researchers want to see if it's safe and effective when used alone or with another medicine called Ruxolitinib. They're also checking how it affects symptoms and red blood cell counts.
For: MyelofibrosisAustralia · Brazil · France - RecruitingPHASE3
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
This study looks at a new drug, Elritercept, for adults with a type of blood disorder called Myelodysplastic Syndromes (MDS). It aims to see if Elritercept can reduce the need for regular blood transfusions and how safe it is.
For: Myelodysplastic SyndromesUnited States · Australia · Brazil - RecruitingPHASE3
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
This study compares Elritercept with Epoetin Alfa for adults with a certain type of Myelodysplastic Syndrome (MDS) and anaemia. It checks if Elritercept reduces the need for blood transfusions and improves tiredness, while also looking at safety.
For: Myelodysplastic Syndrome · AnemiaUnited States · Argentina · Australia - RecruitingPHASE2
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
This study looks at a new medicine called elritercept for adults with a blood condition called Myelodysplastic Syndromes (MDS) who also have anaemia. We want to see how safe it is, how well people tolerate it, and if it helps their bodies make more healthy red blood cells.
For: Myelodysplastic Syndromes · CytopeniaUnited States · Australia · Czechia